Page last updated: 2024-12-06

bromosuccinimide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Bromosuccinimide: A brominating agent that replaces hydrogen atoms in benzylic or allylic positions. It is used in the oxidation of secondary alcohols to ketones and in controlled low-energy brominations. (From Miall's Dictionary of Chemistry, 5th ed; Hawley's Condensed Chemical Dictionary, 12th ed,). [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID67184
CHEBI ID53174
SCHEMBL ID58
SCHEMBL ID7974070
MeSH IDM0002952

Synonyms (77)

Synonym
1-bromo-2,5-pyrrolidinedione
SGCUT00108
bromosuccinimide
2,5-pyrrolidinedione, 1-bromo-
1-bromopyrrolidine-2,5-dione
inchi=1/c4h4brno2/c5-6-3(7)1-2-4(6)8/h1-2h
128-08-5
n-bromosuccimide
nsc16
succinimide, n-bromo-
succinbromimide
NBS ,
succinibromimide
wln: t5vnvtj be
2, 1-bromo-
succinbromide
n-bromosuccinimide ,
nsc-16
TO_000027
ccris 2899
ai3-16619
nsc 16
einecs 204-877-2
n-bromosuccinimide, reagentplus(r), 99%
CHEBI:53174 ,
1-bromo-2,5-pyrrolidine-dione
B0656
AKOS000120001
A805784
n-bromo-succinimide
n-bromosuccinimide (nbs)
n-bromo succinimide
k8g1f2ucjf ,
unii-k8g1f2ucjf
hsdb 8381
ec 204-877-2
STL146592
BP-30011
FT-0645778
SCHEMBL58
SCHEMBL7974070
n-bromosuccinimide [mi]
n-bromobutanimide
n-bromosuccmimide
n-bromo succinimid
n-brornosuccinimide
n-bromopyrrolidine-2,5-dione
n -bromosuccinimide
n-brom-succinimide
jv-bromosuccinimide
n-bromsuccinimide
n-bromo succinic imide
n-bromsuccinimid
1-brompyrrolidine-2,5-dione
n-bromosuccinirnide
n-bromo succinic acid imide
1-bromo-pyrrolidine-2,5-dione
n- bromosuccinimide
n-bromosuccinimid
n-bromosuccinic acid imide
n-bromosuccin-imide
mfcd00005510
DTXSID2038738
n-bromosuccnmde
J-005565
J-523522
CS-W008781
F1908-0173
n-bromosuccinimide, purum, >=95.0% (rt)
D77695
n-bromosuccinimide, for synthesis, 98.0%
BCP15478
Q286939
1-bromodihydro-1h-pyrrole-2,5-dione
AMY24078
n-bromosuccinimide (< 0.1% wt chlorine content)
EN300-20081

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The T1/2α, T1/2β, CL/F, AUC(0-t), MRT, Tmax and Cmax were 18."( Chemiluminescence determination of streptomycin in pharmaceutical preparation and its application to pharmacokinetic study by a flow injection analysis assembly.
Du, B; Jin, J; Li, H; Li, X; Li, Y; Shen, G; Wang, T, 2013
)
0.39

Dosage Studied

ExcerptRelevanceReference
"A titrimetric method is described for the determination of three acetylenic hypnotics, namely ethchlorvynol, ethinamate, and methylpentynol carbamate, in bulk and in dosage forms."( Titrimetric determination of acetylenic hyponotics using organic brominating agents.
Belal, F; el-Brashy, A; Rizk, M; Walash, MI, 1988
)
0.27
" The proposed methods have been successfully applied to the determinations of PPH and PX in various dosage forms."( Indirect spectrophotometric determination of propranolol hydrochloride and piroxicam in pure and pharmaceutical formulations.
Gowda, BG; Melwanki, MB; Seetharamappa, J, 2002
)
0.31
"Three simple, accurate and sensitive colorimetric methods (A, B and C) for the determination of ranitidine HCl (RHCl) in bulk sample, in dosage forms and in the presence of its oxidative degradates are described."( Utility of oxidation-reduction reaction for the determination of ranitidine hydrochloride in pure form, in dosage forms and in the presence of its oxidative degradates.
Ahmed, IS; Amin, AS; Dessouki, HA; Gouda, EA, 2003
)
0.32
" The method has been successfully applied to the determination of the drug in commercial dosage forms."( Spectrophotometric method for the determination of verapamil hydrochloride in pharmaceutical formulations using N-bromosuccinimide as oxidant.
Hejaz Azmi, SN; Rahman, N, 2004
)
0.32
" The proposed method was successfully applied to the analysis of the investigated FQA in their pure and pharmaceutical dosage forms without interference from the common excipients (label claim values were 99."( Evaluation of N-bromosuccinimide as a new analytical reagent for the spectrophotometric determination of fluoroquinolone antibiotics.
Askal, H; Darwish, I; Marzouq, M; Refaat, I, 2007
)
0.34
" The proposed method was successfully applied to the analysis of the above mentioned drugs in bulk substance and in pharmaceutical dosage forms; percent recoveries ranged from 98."( A sensitive spectrophotometric method for the determination of H2-receptor antagonists by means of N-bromosuccinimide and p-aminophenol.
Darwish, IA; Hassan, AI; Hussein, SA; Mahmoud, AM, 2008
)
0.35
"Three simple, accurate, and sensitive colorimetric methods for the determination of cimetidine (Cim) in pure form, in dosage forms, and in the presence of its oxidative degradates were developed."( Colorimetric assay of cimetidine in the presence of its oxidative degradates.
Amin, AS; Dessouki, HA; Gouda, EA; Shama, SA,
)
0.13
"One titrimetric and two spectrophotometric methods which are simple, sensitive and rapid are described for the assay of salbutamol sulphate (SBS) in bulk drug and in tablet dosage forms using N-bromosuccinimide (NBS) and two dyes, rhodamine-B and methylene blue, as reagents."( Rapid titrimetric and spectrophotometric methods for salbutamol sulphate in pharmaceuticals using N-bromosuccinimide.
Basavaiah, K; Ramakrishna, V; Somashekar, BC, 2007
)
0.34
"Three simple, sensitive, precise, reproducible and validated spectrophotometric methods have been developed for the quantification of pipazethate HCl as antitussive drug in pure and dosage forms."( Utilization of N-bromosuccinimide for the sensitive spectrophotometric determination of pipazethate HCl as antitussive drug in pure and dosage forms.
Abourehab, MAS; Ellateif, A; Fawzi, SM; Gouda, AA; Shahin, MHK; Sheikh, RE, 2021
)
0.62
"The developed methods were validated in accordance with ICH guidelines and successfully applied to the analysis of pipazethate HCl in dosage forms with good accuracy and precision."( Utilization of N-bromosuccinimide for the sensitive spectrophotometric determination of pipazethate HCl as antitussive drug in pure and dosage forms.
Abourehab, MAS; Ellateif, A; Fawzi, SM; Gouda, AA; Shahin, MHK; Sheikh, RE, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
reagentA substance used in a chemical reaction to detect, measure, examine, or produce other substances.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
dicarboximideAn imide in which the two acyl substituents on nitrogen are carboacyl groups.
pyrrolidinone
organobromine compoundA compound containing at least one carbon-bromine bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (15)

PathwayProteinsCompounds
quercetin gentiotetraside biosynthesis317
kaempferol gentiobioside biosynthesis317
flavonol glucosylation I118
myricetin gentiobioside biosynthesis316
Joubert syndrome45
myricetin gentiobioside biosynthesis317
hydrogen to trimethylamine N-oxide electron transfer916
(1,3)-u03B2-D-xylan degradation212
N-acetylneuraminate and N-acetylmannosamine degradation I416
CMP-N-acetylneuraminate biosynthesis II (bacteria)521
superpathway of N-acetylglucosamine, N-acetylmannosamine and N-acetylneuraminate degradation924
superpathway of N-acetylneuraminate degradation3979
u03B2-(1,4)-mannan degradation515
superpathway of CMP-sialic acids biosynthesis1460
hydrogen to fumarate electron transfer816
hydrogen to dimethyl sulfoxide electron transfer1015
quercetin gentiotetraside biosynthesis319

Research

Studies (454)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990224 (49.34)18.7374
1990's77 (16.96)18.2507
2000's75 (16.52)29.6817
2010's71 (15.64)24.3611
2020's7 (1.54)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (0.86%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other459 (99.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]